In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.

In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.

Item

http://www.wikidata.org/entity/Q33321671

Q33321671

about

Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus The evidence base for diabetes technology: appropriate and inappropriate meta-analysis Comparison of continuous subcutaneous insulin infusion and insulin glargine-based multiple daily insulin aspart injections with preferential adjustment of basal insulin in patients with type 2 diabetes.Clinical experience with insulin glargine in type 1 diabetes.Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes: a systematic review and meta-analysis.Impact of Real-Time Continuous Glucose Monitoring Use on Glucose Variability and Endothelial Function in Adolescents with Type 1 Diabetes: New Technology--New Possibility to Decrease Cardiovascular Risk?Glucose variability assessed by low blood glucose index is predictive of hypoglycemic events in patients with type 1 diabetes switched to pump therapy.Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study.Insulin therapy with personal insulin pumps and early angiopathy in children with type 1 diabetes mellitus.Dynamic Stress Factor (DySF): A Significant Predictor of Severe Hypoglycemic Events in Children with Type 1 Diabetes Average daily risk range as a measure for clinical research and routine care Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study Clinical Efficacy of Two Different Methods to Initiate Sensor-Augmented Insulin Pumps: A Randomized Controlled Trial.Management of diabetes mellitus: is the pump mightier than the pen?Biological variation of cardiovascular risk factors in patients with diabetes.Variability of glucose-lowering effect as a limiting factor in optimizing basal insulin therapy: a review.Translating glucose variability metrics into the clinic via Continuous Glucose Monitoring: a Graphical User Interface for Diabetes Evaluation (CGM-GUIDE©).Glycemic control after total pancreatectomy for intraductal papillary mucinous neoplasm: an exploratory study.Improved quality of life in unselected insulin pump-treated children with type 1 diabetes in Eastern Nebraska.Assessment of glycemic variability in continuous subcutaneous insulin infusion therapy in type 1 diabetes related to anthropometry and complication status.Computing the risk of postprandial hypo- and hyperglycemia in type 1 diabetes mellitus considering intrapatient variability and other sources of uncertainty.Influence of health locus of control and fear of hypoglycaemia on glycaemic control and treatment satisfaction in people with Type 1 diabetes on insulin pump therapy.Vascular function and glucose variability improve transiently following initiation of continuous subcutaneous insulin infusion in children with type 1 diabetes.The process of incorporating insulin pumps into the everyday lives of people with Type 1 diabetes: A critical interpretive synthesis.Continuous subcutaneous insulin infusion preserves axonal function in type 1 diabetes mellitus.A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus.

P2860

Q24240609-D9843545-6FB4-4CE8-8DFF-E860AA329DCC Q30409804-FCFCF686-8E10-43A4-8D84-D4DD52435328 Q34119580-D6AA1A4E-6D97-488B-BD81-87B5CC6FF0C0 Q34296834-A77013E5-7015-49F3-B381-CEFE251344A4 Q34449270-57D16987-B82A-4E41-9E9D-4EF6B3FBBF33 Q36091280-71DCB7BF-E527-40E7-81AF-8C95134E9FE8 Q36328989-26C9D838-77A8-4DAF-B429-D7C72519F2E1 Q37022673-FCCD6ED2-6605-466B-A190-824742F27E9C Q37235857-F61C3B74-943D-400B-AA4D-F471854D8DDB Q37358869-985AB605-4E08-4134-ADDB-43F988E5659E Q37384180-DA4F89E3-4EBE-471C-A9E8-9611464BCCDF Q37421693-99387D0E-6402-43FE-8EB4-2D2D7879FB9E Q37437141-FD0B641B-E392-4964-A2A2-749EE0CCBE08 Q37492413-7B4C10FA-6B87-4B1D-8E67-C229DEC6C136 Q37988797-93588BF9-0290-41F7-972B-89D43113756B Q38081905-9B58401D-276D-42AC-877A-46A208DE36BB Q38085657-AF0EB227-9B50-4452-98C5-99A436B2F393 Q40571655-C44F307A-8FDB-425D-A903-F3FF4E6D104B Q42100765-B90E7779-7FCD-466F-9E40-EBDD84755384 Q42545434-16494209-D039-42DB-94A1-6D62CFB97BAB Q42599377-F22997DC-1CB5-4A8C-8CD4-54A309258938 Q42599701-AD00C03F-81F4-4082-9FFC-195B58CF5EE8 Q47348006-B6273D7F-FC4A-460E-B04B-908FC19F406D Q49168090-BFBE3C5C-7A89-4896-907B-B3953D9DCD1C Q50123365-7DD9F928-C014-4442-9464-94853E5AA708 Q53489843-9AC94D60-6E8A-435A-A58D-9AE61AED6618 Q55162068-929A0258-7E3D-4280-B345-318F99FCF247

P2860

In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.

Item

http://www.wikidata.org/entity/Q33321671

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu